Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
2.
Am J Crit Care ; 22(3): 270-3, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23635939

RESUMO

Acute generalized exanthematous pustulosis is a rare condition characterized by sterile pustules on erythematous and edematous tissue. Mostly drug induced, this condition can also be caused by other factors. Cases due to vancomycin are rare. A 67-year-old woman with cellulitis of the left lower extremity was admitted with marked bilateral lymphedema of the lower extremities and diffuse erythema of the left lower extremity from foot to knee. She was given clindamycin and then vancomycin. On day 5, her condition worsened, with erythema involving the entire back. Although treatment with clindamycin and vancomycin was discontinued, acute generalized exanthematous pustulosis developed. After successful treatment of other complications, the skin condition improved. Because vancomycin is frequently used, clinicians should be aware of the possibility of acute generalized exanthematous pustulosis. Because the pustulosis decreases after withdrawal of the causative drug, being able to diagnose and differentiate the abnormality from other conditions is prudent.


Assuntos
Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Celulite (Flegmão)/tratamento farmacológico , Clindamicina/efeitos adversos , Eritema/induzido quimicamente , Insuficiência de Múltiplos Órgãos/etiologia , Vancomicina/efeitos adversos , Pustulose Exantematosa Aguda Generalizada/complicações , Idoso , Antibacterianos/administração & dosagem , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Ceftriaxona/administração & dosagem , Ceftriaxona/efeitos adversos , Ceftriaxona/uso terapêutico , Celulite (Flegmão)/complicações , Doença Crônica , Clindamicina/administração & dosagem , Clindamicina/uso terapêutico , Feminino , Hidratação , Humanos , Hipotensão/etiologia , Extremidade Inferior/patologia , Linfedema/complicações , Linfedema/tratamento farmacológico , Obesidade Mórbida , Vancomicina/administração & dosagem , Vancomicina/uso terapêutico , Vasoconstritores/uso terapêutico
4.
Ned Tijdschr Geneeskd ; 157(15): A5809, 2013.
Artigo em Holandês | MEDLINE | ID: mdl-23575292

RESUMO

A 47-year-old man presented to the emergency department with a rapidly progressive, generalized rash and pustulosis shortly after he had started amoxicillin/clavulanic acid for the treatment of a pulmonary infection. Based on the patient's history and the clinical symptoms, the diagnosis of 'acute generalized exanthematous pustulosis' (AGEP) was suspected. This was confirmed by histopathological examination. The skin abnormalities slowly disappeared after terminating antibiotic medication.


Assuntos
Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Combinação Amoxicilina e Clavulanato de Potássio/efeitos adversos , Antibacterianos/efeitos adversos , Pustulose Exantematosa Aguda Generalizada/diagnóstico , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Antibacterianos/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade
11.
Br J Dermatol ; 168(3): 555-62, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23136927

RESUMO

BACKGROUND: Drug patch tests (PTs) can reproduce delayed hypersensitivity to drugs and entail a moderate re-exposure of patients to offending drugs. OBJECTIVES: To determine the value of PTs for identifying the responsible drug in severe cutaneous adverse drug reactions (SCARs) such as acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). METHODS: In a multicentre study, PTs were conducted on patients referred for DRESS, AGEP or SJS/TEN within 1 year of their SCAR. All drugs administered in the 2 months prior to and the week following the onset of the SCAR were tested. RESULTS: Among the 134 patients included (48 male, 86 female; mean age 51·7 years), positive drug PTs were obtained for 24 different drugs. These included positive tests for 64% (46/72) of patients with DRESS, 58% (26/45) of those with AGEP and 24% (4/17) of those with SJS/TEN, with only one relapse of AGEP. The value of PTs depended on the type of drug and the type of SCAR (e.g. carbamazepine was positive in 11/13 DRESS cases but none of the five SJS/TEN cases). PTs were frequently positive for beta lactams (22 cases), pristinamycin (11 cases) and in DRESS with pump proton inhibitors (five cases), but were usually negative for allopurinol and salazopyrin. Of 18 patients with DRESS, eight had virus reactivation and positive PTs. In DRESS, multiple drug reactivity was frequent (18% of cases), with patients remaining sensitized many years later. CONCLUSIONS: PTs are useful and safe for identifying agents inducing SCAR.


Assuntos
Toxidermias/diagnóstico , Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Toxidermias/etiologia , Interações Medicamentosas , Eosinofilia/induzido quimicamente , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes do Emplastro/efeitos adversos , Testes do Emplastro/métodos , Síndrome de Stevens-Johnson/induzido quimicamente , Síndrome de Stevens-Johnson/etiologia , Fatores de Tempo , Adulto Jovem
12.
Dermatol Online J ; 18(11): 5, 2012 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-23217946

RESUMO

Acute generalized exanthematous pustulosis (AGEP) is a clinical reaction pattern characterized by the rapid appearance of widespread sterile, nonfollicular pustules arising within edematous erythematous skin. This aseptic pustular eruption is commonly accompanied by leukocytosis and fever and usually follows recent administration of oral or parenteral drugs. We report two cases of terbinafine-induced AGEP in male patients. Both patients developed a generalized erythroderma with scaling and pruritic pustules 7 and 14 days following initiation of oral terbinafine. With immediate discontinuation of terbinafine and various treatment protocols, both patients demonstrated recovery followed by skin desquamation during the subsequent weeks. Terbinafine is the most frequently used systemic antimycotic and antifungal medication, reflecting its superior efficacy for dermatophyte infections. Despite the appealing drug profile, an awareness of terbinafine-induced AGEP is important given the 5 percent mortality associated with AGEP. Additionally, distinguishing the characteristics of AGEP from those associated with toxic epidermal necrolysis, Stevens-Johnson syndrome, and generalized pustular psoriasis allows for prompt dermatologic evaluation, accurate diagnosis, and appropriate treatment.


Assuntos
Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Antifúngicos/efeitos adversos , Toxidermias/etiologia , Naftalenos/efeitos adversos , Pustulose Exantematosa Aguda Generalizada/tratamento farmacológico , Administração Oral , Adulto , Antifúngicos/administração & dosagem , Antifúngicos/uso terapêutico , Humanos , Masculino , Naftalenos/administração & dosagem , Naftalenos/uso terapêutico , Onicomicose/tratamento farmacológico , Terbinafina
14.
Clin Exp Obstet Gynecol ; 39(3): 414-6, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23157063

RESUMO

BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is an uncommon adverse cutaneous reaction, most commonly associated with drugs. CASE: A 38-year-old primigravida whose labor had been induced developed erythema over her chest and abdomen. She was transferred to our department after a failed vacuum extraction, and delivered a mature infant by forceps. On day three postpartum she developed a 40.4 degrees C fever. Although ceftriaxone was administered, her fever persisted (>38 degreesC). On day six of the puerperium, diffuse non-follicular pustules appeared over her neck and trunk, and AGEP was suspected. Two days after ceftriaxone was withdrawn, the eruptions started to resolve without any medical intervention. CONCLUSION: Once the diagnosis of AGEP has been made, the antibiotics being administered must be discontinued. If continued treatment is required, pharmacologically distinct antibiotics must be used instead to aid the rapid self-limitation of the disease.


Assuntos
Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Pustulose Exantematosa Aguda Generalizada/diagnóstico , Antibacterianos/efeitos adversos , Ceftriaxona/efeitos adversos , Período Pós-Parto , Pustulose Exantematosa Aguda Generalizada/patologia , Adulto , Feminino , Febre , Humanos , Trabalho de Parto Induzido/métodos , Gravidez
20.
Clin Exp Dermatol ; 37(4): 361-3, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22582909

RESUMO

Acute generalized exanthematous pustulosis (AGEP) is an uncommon pustular eruption characterized by small nonfollicular pustules on an erythematous background, sometimes associated with fever and neutrophilia. Over 90% of cases are drug-induced; however, it can be caused in rare cases by other agents. We report two cases of AGEP secondary to ingestion of Pistacia lentiscus essential oil, the first two such cases to our knowledge. The cutaneous morphology, disease course and histological findings were consistent with a definite diagnosis of AGEP, based on the criteria of the EuroSCAR study group. These two cases highlight the need to consider herbal extracts as a potential rare cause of AGEP and to ensure the safety of herbal medicines.


Assuntos
Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Óleos Voláteis/efeitos adversos , Pistacia/efeitos adversos , Extratos Vegetais/efeitos adversos , Antioxidantes/efeitos adversos , Feminino , Humanos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...